Evaluation of a High Throughput Method for the Detection of Mutations Associated with Thrombosis and Hereditary Hemochromatosis in Brazilian Blood Donors

Carregando...
Imagem de Miniatura
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Citação
PLOS ONE, v.10, n.5, article ID UNSP e0125460, 9p, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background The aim of this study was to evaluate the OpenArray platform for genetic testing of blood donors and to assess the genotype frequencies of nucleotide-polymorphisms (SNPs) associated with venous thrombosis (G1691A and G20210A), hyperhomocysteinemia (C677T, A1298C), and hereditary hemochromatosis (C282Y, H63D and S65C) in blood donors from Sao Paulo, Brazil. Methods We examined 400 blood donor samples collected from October to November 2011. The SNPs were detected using OpenArray technology. The blood samples were also examined using a real-time PCR-FRET system to compare the results and determine the accuracy of the OpenArray method. Results We observed 100% agreement in all assays tested, except HFE C282Y, which showed 99.75% agreement. The HFE C282Y assay was further confirmed through direct sequencing, and the results showed that OpenArray analysis was accurate. The calculated frequencies of each SNP were FV G1691A 98.8% (G/G), 1.2% (G/A); FII G2021A 99.5% (G/G), 0.5% (G/A); MTHFR C677T 45.5%(C/C), 44.8% (C/T), 9.8% (T/T); MTHFR A1298C 60.3% (A/A), 33.6% (A/C), 6.1% (C/C); HFE C282Y 96%(G/G), 4%(G/A), HFE H63D 78.1%(C/C), 20.3% (C/G), 1.6% (G/G); and HFE S65C 98.1%(A/A), 1.9% (A/T). Conclusion Taken together, these results describe the frequencies of SNPs associated with diseases and are important to enhance our current knowledge of the genetic profiles of Brazilian blood donors, although a larger study is needed for a more accurate determination of the frequency of the alleles. Furthermore, the OpenArray platform showed a high concordance rate with standard FRET RT-PCR.
Palavras-chave
Referências
  1. Alessio ACM, 2004, AM J MED GENET A, V128A, P256, DOI 10.1002/ajmg.a.30108
  2. Alexander J, 2009, GENET MED, V11, P307, DOI [10.1097/GIM.0b013e31819d30f2, 10.1097/GIM.0b013e31819d3012]
  3. Anstee DJ, 2009, BLOOD, V114, P248, DOI 10.1182/blood-2008-11-146860
  4. Aznar J, 2013, AM J OBSTET GYNECOL, V209, P156, DOI 10.1016/j.ajog.2013.02.036
  5. Bauduer F, 2005, MOL GENET METAB, V86, P91, DOI 10.1016/j.ymgme.2005.04.002
  6. Bernard PS, 1998, AM J PATHOL, V153, P1055, DOI 10.1016/S0002-9440(10)65650-7
  7. BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0
  8. Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0
  9. Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306
  10. Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2
  11. Dalmaz CA, 2006, BLOOD CELL MOL DIS, V37, P107, DOI 10.1016/j.bcmd.2006.07.005
  12. Davis CF, 2010, ANN HEMATOL, V89, P375, DOI 10.1007/s00277-009-0839-y
  13. Sabino AD, 2007, J THROMB THROMBOLYS, V24, P261, DOI 10.1007/s11239-007-0024-x
  14. Delluc A, 2010, THROMB HAEMOSTASIS, V103, P1161, DOI 10.1160/TH09-07-0430
  15. De Stefano V, 2013, THROMB HAEMOSTASIS, V110, P697, DOI 10.1160/TH13-01-0011
  16. De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104
  17. Dusse LMS, 2007, EUR J OBSTET GYN R B, V134, P20, DOI 10.1016/j.ejogrb.2006.09.006
  18. Eldibany MM, 2007, ARCH PATHOL LAB MED, V131, P872
  19. Endler G, 2003, CLIN CHIM ACTA, V330, P31, DOI 10.1016/S0009-8981(03)00022-6
  20. Filho Isaac Lima da Silva, 2011, Arq Neuropsiquiatr, V69, P431
  21. Goette L, 2009, TRANSFUSION, V49, P524, DOI 10.1111/j.1537-2995.2008.02007.x
  22. Jacques PF, 1996, CIRCULATION, V93, P7
  23. Kvasnicka Jan, 2012, Cas Lek Cesk, V151, P76
  24. Lee DH, 1996, CAN MED ASSOC J, V155, P285
  25. Leitman SF, 2013, HEMATOL-AM SOC HEMAT, P645
  26. Lenhard MJ, 2013, TRANSFUSION, V53, P2776, DOI 10.1111/trf.12135
  27. Lima MBPLV, 2009, GENET MOL BIOL, V32, P264, DOI 10.1590/S1415-47572009000200010
  28. Madjunkova S, 2012, GENET TEST MOL BIOMA, V16, P259, DOI 10.1089/gtmb.2011.0173
  29. Mira Y, 2000, CLIN APPL THROMB-HEM, V6, P162, DOI 10.1177/107602960000600308
  30. Morrison T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl639
  31. Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063
  32. Pennings G, 2005, J MED ETHICS, V31, P69, DOI 10.1136/jme.2002.001271
  33. Poort SR, 1996, BLOOD, V88, P3698
  34. Ramos Catarina Paula da Silva, 2008, J. Bras. Patol. Med. Lab., V44, P79, DOI 10.1590/S1676-24442008000200003
  35. Ramos Catarina P. S., 2006, Rev. Bras. Hematol. Hemoter., V28, P131, DOI 10.1590/S1516-84842006000200013
  36. Santos PCJL, 2012, INT J MOL SCI, V13, P1497, DOI 10.3390/ijms13021497
  37. Santos PCJL, 2010, BLOOD CELL MOL DIS, V45, P302, DOI 10.1016/j.bcmd.2010.08.008
  38. Santos PCJL, 2010, BRAZ J MED BIOL RES, V43, P107, DOI 10.1590/S0100-879X2009007500031
  39. Santos RV, 2009, CURR ANTHROPOL, V50, P787, DOI 10.1086/644532
  40. Sazci A, 2006, BRAIN RES BULL, V71, P45, DOI 10.1016/j.brainresbull.2006.07.014
  41. Sottilotta G, 2009, CLIN APPL THROMB-HEM, V15, P356, DOI 10.1177/1076029607310218
  42. Spinola C, 2011, ANN HEMATOL, V90, P29, DOI 10.1007/s00277-010-1034-x
  43. Stur E, 2012, GENET TEST MOL BIOMA, V16, P219, DOI 10.1089/gtmb.2011.0163
  44. Terada CT, 2009, TRANSFUSION MED, V19, P245, DOI 10.1111/j.1365-3148.2009.00944.x
  45. van den Bergh FAJTM, 2000, CLIN CHEM, V46, P1191
  46. Vares M, 2010, AM J MED GENET B, V153B, P610, DOI 10.1002/ajmg.b.31030
  47. Westhoff CM, 2006, CURR OPIN HEMATOL, V13, P471, DOI 10.1097/01.moh.0000245695.77758.3d
  48. Zappacosta B, 2014, CELL BIOCHEM FUNCT, V32, P1, DOI 10.1002/cbf.3019